Lalwani Nikhil — SEC Form 4 filings
SEC reporting owner CIK 1822629. 19 Form 4 filings on record with FilingPulse; latest filed 2026-09-16.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2024-02-16 to 2026-09-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 7 filings — 218,167 shares, $15,980,275 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 56,960 shares @ $85.93 ($4,894,573) in ANI PHARMACEUTICALS INC, filed 2025-08-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO, Director | 19 | — | 9 legs · 218,167 sh · $15,980,275 | 20 |
Form 4 filings — Lalwani Nikhil
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-16 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Sale (S): 5,400 @ $71 | EDGAR |
| 2026-08-26 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Sale (S): 5,400 @ $74.30 | EDGAR |
| 2026-05-13 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Sale (S): 55,000 @ $77.57 | EDGAR |
| 2026-03-10 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 17,060 @ $74.04 | EDGAR |
| 2026-03-02 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Grant/award (A): 75,592 @ $77.15 · Tax withholding (F): 12,217 @ $73.90 | EDGAR |
| 2026-02-17 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 11,688 @ $76.70 · Tax withholding (F): 10,298 @ $77.36 | EDGAR |
| 2026-02-13 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 30,659 @ $76.25 | EDGAR |
| 2025-08-14 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Sale (S): 56,960 @ $85.93 | EDGAR |
| 2025-03-25 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 17,455 @ $64.26 | EDGAR |
| 2025-03-14 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 17,060 @ $60.62 | EDGAR |
| 2025-03-04 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 12,216 @ $61.89 | EDGAR |
| 2025-02-18 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Grant/award (A): 91,399 @ $0 · Grant/award (A): 60,932 @ $0 · Tax withholding (F): 7,799 @ $58.92 | EDGAR |
| 2024-11-27 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Option exercise (M): 30,000 @ $29 · Sale (S): 30,000 @ $57.95 · Sale (S): 3,481 @ $58.30 · Option exercise (M): 30,000 (derivative) @ $29 | EDGAR |
| 2024-09-10 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 3,646 @ $60.51 | EDGAR |
| 2024-05-16 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Sale (S): 16,669 @ $66.10 | EDGAR |
| 2024-03-25 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 17,455 @ $69.58 | EDGAR |
| 2024-03-08 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Sale (S): 28,965 @ $65.52 · Tax withholding (F): 17,060 @ $66.71 · Sale (S): 16,292 @ $67.13 | EDGAR |
| 2024-03-01 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 10,014 @ $67.67 | EDGAR |
| 2024-02-16 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Grant/award (A): 80,530 @ $0 · Grant/award (A): 53,686 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1822629 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →